Clinical Trial Update: Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients

View source ↗

Summary

Completed study evaluating the effects of raloxifene on the uterus and ovaries in premenopausal women with breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Raloxifene (raloxifene)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Breast Cancer, Breast Neoplasm | Status: COMPLETED